CETX

CETX Spikes 125% Pre-Market on Navy SBIR Contract Win

April 7, 2026 — 9:12 AM EDT | Free Equity Reports Research

Momentum Plays Defense Stocks SBIR Contracts Aerospace Small Cap Pre-Market Movers
Price $1.79
Change +124.98%
Volume 1.06M
Float ~4.5M
Mkt Cap $8.02M

Time of Analysis: April 7, 2026, 9:11 AM ET

Key Data:

  • Price: $1.79 (+124.98%)
  • Previous Close: $0.80
  • Volume: 1.06M (last session)
  • Float: ~4.5M shares
  • Market Cap: $8.02M

The street’s sleeping on what just happened here. CETX hit $1.79 in pre-market trading, more than doubling from Friday’s close, after announcing that subsidiary Invocon won a U.S. Navy SBIR Phase I contract for naval mine warfare technology. This isn’t random—it’s validation of a strategic bet most people wrote off as desperation.

Let’s cut through the noise. Cemtrex completed its $7.06M acquisition of Invocon in January, formally launching an Aerospace & Defense segment. Wall Street yawned. The stock kept bleeding. But here’s what they missed: Invocon generates $7.4 million in annual revenue with existing contracts including Missile Defense Agency programs.

The Navy SBIR win isn’t just a contract—it’s proof of concept for the broader thesis. Invocon has 40 years of flight-proven hardware experience across shuttle missions, ISS systems, and advanced sensing technologies, with multiple patents in hypervelocity impact detection and lethality assessment. These aren’t garage startups competing for SBIR dollars. They’re battle-tested engineers with existing clearances and relationships.

Here’s the tape read: CETX bottomed at $0.53 in late March, right around the time smart money probably started positioning ahead of the Invocon integration. The 125% pre-market gap puts us above the $1.50 resistance that’s been capping rallies since the reverse split. If volume stays heavy above 2M shares, this breaks through to the $2.50-3.00 zone where real short covering begins.

The risk framework hasn’t changed much. The company still burns cash with -$28.1M net income on $76.5M revenue, and recent registered direct offerings in December funded operations but pressured shares. This is still a sub-$10M market cap micro with execution risk written all over it.

But the contrarian angle is getting interesting. Technical models remain overwhelmingly bearish despite growing revenue and new defense contracts, highlighting heavy short interest and expecting continued downtrend. When the algos are this pessimistic and the fundamental story keeps improving, gaps like today’s tend to stick.

The aerospace pivot isn’t theoretical anymore. Invocon has contracts under the Missile Defense Agency’s SHIELD program and aims to expand proposal activity across missile defense and aerospace programs. Defense budgets aren’t shrinking, and the Navy just validated their technology with real money.

What to watch: Volume above 3M confirms institutional interest beyond retail FOMO. Hold above $1.50 and this runs toward $2.50. Break below $1.20 and it’s just another small-cap head fake. The real test comes when they report Q1 numbers in May—will Invocon’s contribution show up in the margins, or is this still a cash-burning transformation story?

Risk management: This isn’t IBM. Position size for volatility. The float’s tight, the fundamentals are messy, and SBIR contracts don’t guarantee profitability. But sometimes the best setups look exactly this risky when everyone else is looking the other way.

This analysis is for informational purposes only and not a recommendation to buy or sell securities.

This report is for informational purposes only and does not constitute investment advice. Always conduct your own due diligence before making any investment decision.